EfficAcy and SafetY of Cold Forceps Biopsy for diminutive pharyngeal neoplasms: a randomized controlled trial

EfficAcy and SafetY of Cold Forceps Biopsy for diminutive pharyngeal neoplasms: a randomized controlled trial - EASY-CFB trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045220

Enrollment

124

Registered

2021-08-24

Start date

2021-08-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharyngeal neoplasm

Interventions

Jumbo biopsy forceps Standard biopsy forceps

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diminutive (less than 3mm) pharyngeal neoplasm diagnosed by endoscopic images

Exclusion criteria

Exclusion criteria: 1. Patients with coagulopathy or hemorrhagic disease 2. Pregnancy, breast feeding 3. Patients taking multiple antithrombotic agents

Design outcomes

Primary

Measure	Time frame
Endoscopic recurrence rate 3 months after CFB	—

Secondary

Measure	Time frame
Pathological recurrence rate 3 months after CFB, Endoscopic and pathological recurrence rate 12 months after CFB, immediate and delayed bleeding rate, any other adverse events	—

Countries

Japan

Contacts

Public ContactYuichi Shimodate

Kurashiki Central Hospital Gastroenterology and Hepatology

ys13544@kchnet.or.jp+81864220210

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026